Riccardo Polosa: Difference between revisions
Content deleted Content added
m Fix |
Tagging with {{Academic-bio-stub}} (StubTagTab) |
||
| Line 1: | Line 1: | ||
'''[[Riccardo Polosa|Riccardo]] Polosa''' is researcher into cures to smoking related diseases and alternative tools for smoking cessation. His work contributed to a paper finding that "e-cigarettes were 95% less harmful than tobacco cigarettes". This finding has been criticized by [[The Lancet]]. Polosa has been a consultant for the e-cigarette distributor Arbi Group Srl. <ref>{{cite news|url=https://www.highbeam.com/doc/1P2-39957086.html|title=Health Board Alters Stance on E-Cigarettes|newspaper=The Herald|date=16 December 2015|first=Marck|last=Eddie}}{{highbeam}}</ref> Acording to a paper published in ''BMC Public Health'' he is, as of 2014, the most prolific author in the field of electronic cigarettes. <ref>{{cite journal|journal=BMC Public Health|url=http://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-14-667|title=Worldwide research productivity in the field of electronic cigarette: a bibliometric analysis|first=Sa'ed H|last=Zyoud|date=30 June 2014</ref> He is also the author of the first prospective randomized study with a control group that evaluated the efficacy and safety of electronic cigarettes on a sample of 300 smokers unwilling to quit.<ref>[http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0066317 Plose One, ECLAT EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as Tobacco Cigarettes Substitute: A Prospective 12-Month Randomized Control Design Study]</ref> |
'''[[Riccardo Polosa|Riccardo]] Polosa''' is researcher into cures to smoking related diseases and alternative tools for smoking cessation. His work contributed to a paper finding that "e-cigarettes were 95% less harmful than tobacco cigarettes". This finding has been criticized by [[The Lancet]]. Polosa has been a consultant for the e-cigarette distributor Arbi Group Srl. <ref>{{cite news|url=https://www.highbeam.com/doc/1P2-39957086.html|title=Health Board Alters Stance on E-Cigarettes|newspaper=The Herald|date=16 December 2015|first=Marck|last=Eddie}}{{highbeam}}</ref> Acording to a paper published in ''BMC Public Health'' he is, as of 2014, the most prolific author in the field of electronic cigarettes. <ref>{{cite journal|journal=BMC Public Health|url=http://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-14-667|title=Worldwide research productivity in the field of electronic cigarette: a bibliometric analysis|first=Sa'ed H|last=Zyoud|date=30 June 2014}}</ref> He is also the author of the first prospective randomized study with a control group that evaluated the efficacy and safety of electronic cigarettes on a sample of 300 smokers unwilling to quit.<ref>[http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0066317 Plose One, ECLAT EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as Tobacco Cigarettes Substitute: A Prospective 12-Month Randomized Control Design Study]</ref> |
||
==References== |
==References== |
||
<references /> |
<references /> |
||
{{Academic-bio-stub}} |
|||
Revision as of 15:05, 24 February 2017
Riccardo Polosa is researcher into cures to smoking related diseases and alternative tools for smoking cessation. His work contributed to a paper finding that "e-cigarettes were 95% less harmful than tobacco cigarettes". This finding has been criticized by The Lancet. Polosa has been a consultant for the e-cigarette distributor Arbi Group Srl. [1] Acording to a paper published in BMC Public Health he is, as of 2014, the most prolific author in the field of electronic cigarettes. [2] He is also the author of the first prospective randomized study with a control group that evaluated the efficacy and safety of electronic cigarettes on a sample of 300 smokers unwilling to quit.[3]
References
- ^ Eddie, Marck (16 December 2015). "Health Board Alters Stance on E-Cigarettes". The Herald. – via HighBeam (subscription required)
- ^ Zyoud, Sa'ed H (30 June 2014). "Worldwide research productivity in the field of electronic cigarette: a bibliometric analysis". BMC Public Health.
- ^ Plose One, ECLAT EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as Tobacco Cigarettes Substitute: A Prospective 12-Month Randomized Control Design Study
 | This biography of an academic is a stub. You can help Wikipedia by expanding it. |